Are you sure you want to leave this community? Leaving the community will revoke any permissions you have been granted in this community.
Cell therapy using mesenchymal stromal cells (MSCs) offers new perspectives in the treatment of traumatic brain injury (TBI). The aim of the present study was to assess the impact of platelet-rich plasma scaffolds (PRPS) as support of MSCs in a delayed phase after severe TBI in rats.
Pubmed ID: 29306567